NuCana PLC (NCNA)
4.00
+0.04
(+0.88%)
USD |
NASDAQ |
May 03, 16:00
4.00
0.00 (0.00%)
After-Hours: 20:00
NuCana Enterprise Value: -13.49M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | -13.49M |
| May 02, 2024 | -13.56M |
| May 01, 2024 | -13.53M |
| April 30, 2024 | -13.57M |
| April 29, 2024 | -13.49M |
| April 26, 2024 | -13.49M |
| April 25, 2024 | -13.89M |
| April 24, 2024 | -13.82M |
| April 23, 2024 | -13.49M |
| April 22, 2024 | -13.51M |
| April 19, 2024 | -13.96M |
| April 18, 2024 | -13.93M |
| April 17, 2024 | -13.55M |
| April 16, 2024 | -13.70M |
| April 15, 2024 | -12.53M |
| April 12, 2024 | -10.11M |
| April 11, 2024 | -9.436M |
| April 10, 2024 | -9.436M |
| April 09, 2024 | -9.394M |
| April 08, 2024 | -9.468M |
| April 05, 2024 | -9.642M |
| April 04, 2024 | -9.294M |
| April 03, 2024 | -8.078M |
| April 02, 2024 | -9.796M |
| April 01, 2024 | -9.415M |
| Date | Value |
|---|---|
| March 28, 2024 | -8.199M |
| March 27, 2024 | -5.733M |
| March 26, 2024 | -5.768M |
| March 25, 2024 | -5.356M |
| March 22, 2024 | -5.868M |
| March 21, 2024 | -6.629M |
| March 20, 2024 | -4.356M |
| March 19, 2024 | -4.266M |
| March 18, 2024 | -2.543M |
| March 15, 2024 | -3.511M |
| March 14, 2024 | -1.285M |
| March 13, 2024 | 0.2583M |
| March 12, 2024 | -1.614M |
| March 11, 2024 | -4.499M |
| March 08, 2024 | -4.425M |
| March 07, 2024 | -4.499M |
| March 06, 2024 | -4.906M |
| March 05, 2024 | -4.552M |
| March 04, 2024 | -4.499M |
| March 01, 2024 | -5.028M |
| February 29, 2024 | -5.028M |
| February 28, 2024 | -4.589M |
| February 27, 2024 | -4.531M |
| February 26, 2024 | -4.520M |
| February 23, 2024 | -5.556M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-42.87M
Minimum
Mar 08 2022
413.62M
Maximum
May 06 2019
68.83M
Average
36.22M
Median
Feb 15 2023
Enterprise Value Benchmarks
| Adaptimmune Therapeutics PLC | 146.78M |
| Biodexa Pharmaceuticals Plc | -2.432M |
| Autolus Therapeutics PLC | 874.67M |
| Mereo BioPharma Group PLC | 404.26M |
| Bicycle Therapeutics PLC | 435.37M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.507M |
| Total Expenses (Quarterly) | 10.12M |
| EPS Diluted (Quarterly) | -4.657 |
| Earnings Yield | -411.5% |